Skip to content
Clinical Trials – home

Post procedural pulmonary embolism

1 / 1 trials open to patients2 countries

In short

Post procedural pulmonary embolism is a serious and potentially life-threatening complication that can occur after surgical procedures, ranking as the third most common cause of cardiovascular death worldwide.

What Is Post Procedural Pulmonary Embolism?

A post procedural pulmonary embolism is a severe complication that can develop after surgical procedures. It happens when a blood clot, typically formed in a deep vein thrombosis (DVT) in the legs, travels through the bloodstream and becomes lodged in the arteries of the lungs. This blocks blood flow to the lungs and prevents proper oxygen circulation throughout the body.

When a clot obstructs the pulmonary arteries, it restricts blood flow to the lungs, lowers oxygen levels, and increases blood pressure in the pulmonary arteries. This puts significant strain on both the lungs and heart, which can lead to lung damage, heart failure, or even death if not treated quickly.

The condition is a significant cause of illness and death in surgical patients. Post procedural pulmonary embolism is the third most common cause of cardiovascular death worldwide, after stroke and heart attack. In the United States, about 900,000 people experience a pulmonary embolism each year, with many cases occurring after surgery.

What Causes This Condition and Who Is at Risk?

The primary cause of post procedural pulmonary embolism is blood clot formation during or after surgery. During and after surgical procedures, blood can pool in the veins due to prolonged periods of physical inactivity. When blood pools and does not circulate well, clots can form. These clots can then break free and travel to the lungs.

The risk is particularly high following major surgery on the abdomen, pelvis, or legs. Surgery involving the extremities carries especially high risk because of the increased likelihood of deep vein thrombosis developing in the legs.

Several factors increase a person's risk of developing a pulmonary embolism after surgery. Risk factors include prolonged immobility during and after the procedure, major surgery, advanced age, obesity, and a history of previous blood clots or thromboembolic events. People with certain inherited or acquired conditions that make blood more likely to clot, known as hypercoagulable states, are also at increased risk.

Other medical conditions can also raise the risk. These include cancer, inflammatory disorders, heart conditions such as congestive heart failure or atrial fibrillation, and the use of hormone replacement therapy or birth control pills.

When Can It Happen After Surgery?

Post procedural pulmonary embolism can occur from a few hours to several weeks after surgery. The risk is highest during the first five weeks following a surgical procedure, with the peak risk occurring between one and six weeks after surgery.

Research has shown that for several types of surgery, the risk of pulmonary embolism can remain elevated for up to 12 weeks in total. After 18 weeks, the risk typically returns to normal levels.

The timing can vary depending on the type and extent of surgery performed. Some cases develop very rapidly—within hours after surgery—while others may take days or weeks to appear. The urgency of this condition cannot be overstated, as deaths have been reported within four hours of symptom onset.

Warning Signs and Symptoms

Recognizing the symptoms of post procedural pulmonary embolism is critical because early treatment can be lifesaving. The symptoms can vary depending on the size of the clot, and some people may experience symptoms over several days or weeks, while others develop symptoms suddenly.

The most common early signs are sudden shortness of breath and chest pain. These symptoms typically worsen with physical exertion or when taking a deep breath.

Other symptoms to watch for include:

  • Rapid or fast breathing
  • Chest pain that may feel similar to a heart attack
  • Pain in the arm, shoulder, neck, or jaw
  • Rapid heartbeat
  • Cough, sometimes with bloody mucus (called hemoptysis)
  • Dizziness or lightheadedness
  • Pale, clammy, or bluish-colored skin
  • Excessive sweating
  • Pain, swelling, discoloration, or tenderness in the leg or arm
  • Feeling anxious or faint

Although most people with a pulmonary embolism will experience some symptoms, not everyone does initially. Some people may have mild symptoms that appear gradually over days or weeks.

Anyone experiencing these symptoms after surgery should seek medical attention immediately. This is a medical emergency that requires prompt diagnosis and treatment.

How Doctors Diagnose the Condition

Diagnosing post procedural pulmonary embolism can be challenging, especially in patients who have underlying heart or lung conditions. Doctors use several methods to confirm the diagnosis, including reviewing medical history, performing a physical examination, and ordering specific tests.

During a physical exam, a doctor will check for swollen or discolored areas on the arms or legs, listen to the heart and lungs, and take blood pressure readings.

Blood tests are often the first diagnostic step. Doctors may order a D-dimer blood test, which measures a substance that appears in the bloodstream when a blood clot dissolves. High levels can indicate the presence of a blood clot. Blood tests can also measure oxygen and carbon dioxide levels in the blood, as a clot in the lung may lower oxygen levels.

Medical imaging tests provide the most definitive diagnosis. Computed tomographic pulmonary angiography (CTPA) is considered the gold standard for diagnosing pulmonary embolism. This test uses X-rays to create detailed cross-sectional images of the chest and can clearly show blood clots in the lungs.

Other imaging tests may include chest X-rays, which can rule out other conditions with similar symptoms, and ultrasound examinations of the legs to check for deep vein blood clots. A test called duplex ultrasonography uses sound waves to scan veins and detect blood clots in the legs.

Early diagnosis is highly recommended because immediate and appropriate treatment can be lifesaving. Delays in diagnosis and treatment can result in death within minutes to hours.

Treatment Options

Treatment for post procedural pulmonary embolism focuses on stopping the current clot from getting larger and preventing new clots from forming. The treatment approach depends on the severity of the condition and the patient's overall health.

Anticoagulation therapy (blood thinners) is the most common treatment. These medications make it harder for blood to clot, which helps prevent new clots from forming and stops existing clots from enlarging. While blood thinners cannot dissolve existing clots, the body often dissolves them naturally over time.

Thrombolytic therapy involves medications that actively dissolve blood clots. This treatment is typically reserved for patients with severe, life-threatening pulmonary embolism, particularly those with low blood pressure. Thrombolytic drugs have shown great success in treating acute pulmonary embolism, though they carry a higher risk of bleeding complications.

For some patients, surgical procedures may be necessary. A thrombectomy is a surgical procedure to physically remove the blood clot from the lung arteries. Another surgical option is placement of an inferior vena cava (IVC) filter, which is a small device inserted into the large vein that carries blood from the lower body to the heart. This filter catches blood clots before they can reach the lungs.

In some cases, doctors may use catheter-directed procedures, where a thin tube is threaded through blood vessels to reach and treat the clot directly. These procedures can deliver clot-dissolving medications directly to the clot or mechanically break it up.

While surgical treatments can be lifesaving, many medical professionals favor medical therapy with anticoagulants and thrombolytics as the first choice of treatment.

Preventing Pulmonary Embolism After Surgery

Prevention is critical because post procedural pulmonary embolism is a serious and potentially fatal complication. Healthcare providers must maintain a high level of suspicion and implement rigorous preventive measures to reduce the risk in surgical patients.

The most important preventive measures include anticoagulant drugs given before and after surgery, known as prophylaxis. Studies have shown statistically significant results supporting the use of prophylaxis in preventing pulmonary embolism after surgery.

Mechanical compression devices are another key preventive tool. These include compression stockings or pneumatic compression devices that apply pressure to the legs, helping to keep blood circulating and preventing clot formation during and after surgery.

Early mobilization is also crucial. Getting patients moving as soon as safely possible after surgery helps promote blood circulation and reduces the risk of clot formation. Even simple exercises like flexing the ankles while in bed can help maintain blood flow.

A thorough preoperative assessment is essential. Doctors should carefully evaluate each patient's individual risk factors for developing blood clots and implement appropriate preventive measures based on that assessment.

For patients at high risk, additional monitoring and preventive strategies may be necessary. The key to successful prevention lies in identifying risk factors before surgery and using appropriate preventive measures tailored to each patient's needs.

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Post procedural pulmonary embolism

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rosuvastatin Calcium
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest
See all 1 trials →filters applied: condition = Post procedural pulmonary embolism

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).